Polyribosome metabolism in growing and nongrowing Escherichia coli.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D001433:Bacteriolysis; D001665:Binding Sites; D002701:Chloramphenicol / Q000494:pharmacology; D003864:Depression, Chemical; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D005672:Fusidic Acid / Q000494:pharmacology; D008660:Metabolism / Q000187:drug effects; D008954:Models, Biological; D008961:Models, Structural; D009355:Neomycin / Q000494:pharmacology; D010455:Peptides / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism*; D012293:Rifampin / Q000494:pharmacology; D000198:Spectinomycin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D010455:Peptides; D012333:RNA, Messenger; D005672:Fusidic Acid; D002701:Chloramphenicol; D012343:RNA, Transfer; D000198:Spectinomycin; D009355:Neomycin; D012293:Rifampin; D013307:Streptomycin